Your browser doesn't support javascript.
loading
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.
Aoki, Tomokazu; Kagawa, Naoki; Sugiyama, Kazuhiko; Wakabayashi, Toshihiko; Arakawa, Yoshiki; Yamaguchi, Shigeru; Tanaka, Shota; Ishikawa, Eiichi; Muragaki, Yoshihiro; Nagane, Motoo; Nakada, Mitsutoshi; Suehiro, Satoshi; Hata, Nobuhiro; Kuroda, Junichiro; Narita, Yoshitaka; Sonoda, Yukihiko; Iwadate, Yasuo; Natsumeda, Manabu; Nakazato, Yoichi; Minami, Hironobu; Hirata, Yuki; Hagihara, Shunsuke; Nishikawa, Ryo.
Affiliation
  • Aoki T; Department of Neurosurgery, National Hospital Organization Kyoto Medical Center, 1-1 Fukakusa Mukaihatacho, Fushimi Ward, Kyoto, 612-8555, Japan. totorolangdom@yahoo.co.jp.
  • Kagawa N; Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Sugiyama K; Department of Clinical Oncology and Neuro-Oncology Program, Hiroshima University Hospital, Hiroshima, Japan.
  • Wakabayashi T; Department of Neurosurgery, Nagoya University Hospital, Nagoya, Japan.
  • Arakawa Y; Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Yamaguchi S; Department of Neurosurgery, Hokkaido University Hospital, Hokkaido, Japan.
  • Tanaka S; Department of Neurosurgery, The University of Tokyo Hospital, Tokyo, Japan.
  • Ishikawa E; Department of Neurosurgery, University of Tsukuba Hospital, Ibaraki, Japan.
  • Muragaki Y; Department of Neurosurgery, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Nagane M; Faculty of Medicine, Department of Neurosurgery, Kyorin University, Tokyo, Japan.
  • Nakada M; Department of Neurosurgery, Kanazawa University Hospital, Kanazawa, Japan.
  • Suehiro S; Department of Neurosurgery, Ehime University Hospital, Ehime, Japan.
  • Hata N; Department of Neurosurgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kuroda J; Department of Neurosurgery, Kumamoto University Hospital, Kumamoto, Japan.
  • Narita Y; Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Sonoda Y; Department of Neurosurgery, Yamagata University Hospital, Yamagata, Japan.
  • Iwadate Y; Department of Neurological Surgery, Chiba University Hospital, Chiba, Japan.
  • Natsumeda M; Department of Neurosurgery, Niigata University Medical and Dental Hospital, Niigata, Japan.
  • Nakazato Y; Hidaka Center for Pathologic Diagnosis and Research, Hidaka Hospital, Gunma, Japan.
  • Minami H; Department Medical Oncology/Hematology, Kobe University, Kobe, Japan.
  • Hirata Y; Oncology Early Clinical Development Planning, Ono Pharmaceutical Co., Ltd, Osaka, Japan.
  • Hagihara S; Department of Statistical Analysis, Ono Pharmaceutical Co., Ltd, Osaka, Japan.
  • Nishikawa R; Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan.
Int J Clin Oncol ; 26(12): 2205-2215, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34586548
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Nivolumab Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glioblastoma / Nivolumab Type of study: Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Int J Clin Oncol Journal subject: NEOPLASIAS Year: 2021 Type: Article Affiliation country: Japan